Paegelow I, Werner H, Vietinghoff G, Wartner U
Institute of Pharmacology and Toxicology, University of Rostock, Germany.
Inflamm Res. 1995 Jul;44(7):306-11. doi: 10.1007/BF02032574.
Bradykinin as an inflammatory mediator was assayed for its ability to release cytokines from isolated lung tissue derived from guinea pigs, mice and in some cases from patients. Bradykinin elicited in concentrations, which were able to induce a contraction of isolated lung strips, a secretion of different cytokines from the tissue into organ baths as well as from lung tissue incubated in petri dishes (4h, 37 degrees C). Using enzyme immuno assays and the tanned erythrocyte electrophoretic mobility (TEEM)-test in combination with monoclonal antibodies the cytokines could be identified preferably as interleukin(IL)-1, IL-2, sIL-2R and IL-6. Tyrode solution as a control and carbachol in a concentration causing also a contraction were not able to release cytokines in a significant amount. The bradykinin B2 receptor antagonist icatebant (HOE 140) inhibited the bradykinin-induced IL-2 and IL-6 release. The results show that bradykinin can elicit the secretion of the cytokine cascade via a receptor-mediated process.
缓激肽作为一种炎症介质,对其从豚鼠、小鼠以及某些情况下从患者分离出的肺组织中释放细胞因子的能力进行了测定。缓激肽在能够诱导离体肺条收缩的浓度下,会促使组织向器官浴以及在培养皿中孵育的肺组织(4小时,37摄氏度)分泌不同的细胞因子。使用酶免疫测定法以及鞣酸红细胞电泳迁移率(TEEM)试验并结合单克隆抗体,这些细胞因子主要可鉴定为白细胞介素(IL)-1、IL-2、可溶性IL-2受体(sIL-2R)和IL-6。作为对照的台氏液以及能引起收缩的浓度的卡巴胆碱,均不能大量释放细胞因子。缓激肽B2受体拮抗剂依替班特(HOE 140)抑制了缓激肽诱导的IL-2和IL-6释放。结果表明,缓激肽可通过受体介导的过程引发细胞因子级联反应的分泌。